| http://www.w3.org/ns/prov#value | - BioTime, Inc. (NYSE: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with Geron Corporation (Nasdaq: GERN) to acquire the intellectual property, including patents and patent applications, and other assets related to Geron???s human embryonic stem (hES) cell programs consisten
|
